Publicaciones (91) Publicaciones de RAFAEL SALGUERO BODES

2024

  1. Paradoxical interatrial conduction recovery after cavotricuspid isthmus ablation: A case report

    Journal of Electrocardiology, Vol. 82, pp. 69-72

  2. Symptom burden guiding invasive electrophysiological study in paroxysmal supraventricular tachycardia: The believe SVT registry

    American Heart Journal, Vol. 269, pp. 15-24

2023

  1. Compatibility of a novel temperature-controlled, irrigated radiofrequency catheter with ultra-high-density mapping

    Journal of Arrhythmia, Vol. 39, Núm. 4, pp. 676-680

  2. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  3. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 862-871

  4. Inteligencia Artificial aplicada a los datos obtenidos del seguimiento remoto del marcapasos: Justificación y diseño del estudio prospectivo IA-PACING

    I+S: Revista de la Sociedad Española de Informática y Salud, Núm. 155, pp. 13-16

  5. Sex differences in patterns of referral and resource utilization in the cardiology clinic: an outpatient analysis

    Frontiers in Cardiovascular Medicine, Vol. 10

  6. Systematic Workflow and Electrogram guidance to reduce X-ray Exposure Time during cryoballoon ablation of atrial fibrillation: the SWEET-Cryo strategy

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 9

  7. Ten years of the RECALCAR registry: reflections on cardiovascular care in Spain

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 500-502

2022

  1. Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure

    Cardiac Failure Review, Vol. 8

  2. Homozygous Pro1066Arg MYBPC3 Pathogenic Variant in a 26Mb Region of Homozygosity Associated with Severe Hypertrophic Cardiomyopathy in a Patient of an Apparent Non-Consanguineous Family

    Life, Vol. 12, Núm. 7

  3. Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 710-717

  5. Response by Caravaca Pérez et al to Letter Regarding Article, "potential Role of Natriuretic Response to Furosemide Stress Test during Acute Heart Failure"

    Circulation: Heart Failure

  6. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

    The Lancet, Vol. 399, Núm. 10333, pp. 1383-1390

  7. Situación del Código Infarto tras la fase inicial de la pandemia de la COVID-19.: Experiencia en un centro de alto volumen

    REC: Interventional Cardiology, Vol. 4, Núm. 2, pp. 147-149

  8. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23

    BMC Medicine, Vol. 20, Núm. 1

  9. The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?

    Pulmonary Circulation, Vol. 12, Núm. 4

2021

  1. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

    Hellenic Journal of Cardiology, Vol. 62, Núm. 2, pp. 152-157

  2. Byophisical Characterization and Procedural Outcomes of Irrigated, Temperature-Controlled Radiofrequency Ablation of Macroreentrant Atrial Tachycardia

    SSRN Electronic Journal